Featured Research

from universities, journals, and other organizations

Scientists Identify New Sperm Protein Required For Fertilization

Date:
August 27, 2003
Source:
Emory University Health Sciences Center
Summary:
In the United States, nearly 2.6 million couples have been treated for infertility with about 40 percent of those cases thought to be due to male infertility. Now, a study published in the August 22 issue of Cell identifies a new protein that is required for a sperm to bind to an egg during the process of fertilization.

ATLANTA -- In the United States, nearly 2.6 million couples have been treated for infertility with about 40 percent of those cases thought to be due to male infertility. Now, a study published in the August 22 issue of Cell identifies a new protein that is required for a sperm to bind to an egg during the process of fertilization. This research provides important new insight into the molecular mechanisms that are involved in the initial events of sperm-egg association and may shed light on what underlies some instances of male infertility.

There are a variety of factors that can lead to male infertility, including defects in sperm motility and insufficient sperm production. However, in many cases, the sperm of infertile men appear to be completely normal. Barry D. Shur, PhD, professor and chair of cell biology at Emory University School of Medicine, and postdoctoral fellow Michael A. Ensslin, PhD, took a close look at the specific molecules and events required for a sperm to recognize an egg so that fertilization can take place. The researchers identified a protein on the surface of mouse sperm that is required for the sperm to successfully bind to the outside of the egg. The protein, called SED1, binds specifically to unfertilized eggs and no longer recognizes an egg after it has been fertilized. When examined in the laboratory, sperm without SED1 were unable to bind to an egg. Further, mice without SED1 had greatly reduced fertility even though the sperm appeared normal in number and motility.

These results strongly suggest that SED1 plays a critical role in the initial association between sperm and egg. "An understanding of the molecular mechanisms underlying sperm-egg binding may give insight into the basis for at least some percentage of male infertility," explains Dr. Shur. "In addition, this work is of interest because the composition of SED1 is similar to other types of cell-cell binding proteins, which have not previously been implicated in sperm-egg binding."


Story Source:

The above story is based on materials provided by Emory University Health Sciences Center. Note: Materials may be edited for content and length.


Cite This Page:

Emory University Health Sciences Center. "Scientists Identify New Sperm Protein Required For Fertilization." ScienceDaily. ScienceDaily, 27 August 2003. <www.sciencedaily.com/releases/2003/08/030826064928.htm>.
Emory University Health Sciences Center. (2003, August 27). Scientists Identify New Sperm Protein Required For Fertilization. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2003/08/030826064928.htm
Emory University Health Sciences Center. "Scientists Identify New Sperm Protein Required For Fertilization." ScienceDaily. www.sciencedaily.com/releases/2003/08/030826064928.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins